谷歌浏览器插件
订阅小程序
在清言上使用

Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (anifrolumab) in Patients with Type I Interferonopathies.

Genia Kretzschmar, Laura Piñero Páez,Ziyang Tan, Jun Wang, Laura Gonzalez,Constantin Habimana Mugabo, Anette Johnsson,Yang Chen, Jaromír Mikeš,Tadepally Lakshmikanth,Anna James, Raphaela Goldbach-Mansky, Marie Fischer,Karin Palmblad,Sara Alehashemi, AnnaCarin Horne,Petter Brodin

JOURNAL OF CLINICAL IMMUNOLOGY(2025)

引用 0|浏览1
暂无评分
关键词
IFN-I,type I IFN,IFNAR1,Interferonopathies,Anifrolumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要